MRK vs WFC: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Wells Fargo & Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Merck & Co., Inc. · Healthcare
$113.87
-12.1% upside to fair value
Grade D
High Quality
VS
Wells Fargo & Company · Financial Services
$87.53
+18.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
WFC has more upside to fair value
(+18.1%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
WFC |
| Current Price |
$113.87 |
$87.53 |
| Fair Value Estimate |
$100.14 |
$103.38 |
| Upside to Fair Value |
-12.1%
|
+18.1%
|
| Market Cap |
$281.2B |
$267.8B |
| Forward P/E |
32.0x
|
—
|
| EV / EBITDA |
17.3x
|
15.8x
|
| Price / Sales |
4.3x
|
2.1x
|
| Price / FCF |
19.9x
|
226.4x
|
| Revenue Growth YoY |
+4.3%
|
+11.3%
|
| Gross Margin |
75.9%
|
64.5%
|
| Operating Margin |
27.6%
|
21.2%
|
| Return on Equity |
17.9%
|
12.6%
|
| Dividend Yield |
0% |
2.06% |
| FCF Yield |
5.02%
|
0.44%
|
| Analyst Consensus |
Hold
|
Hold
|
Investment Thesis
Merck & Co., Inc. is a leading global healthcare company specializing in pharmaceuticals, vaccines, and animal health products. Its business quality is high, supported by a durable competitive moat anchored in the dominant global position of Keytruda in PD-1/PD-L1 oncology, a strong vaccines portfolio including Gardasil, and scale in R&D and manufacturing. The company benefits from a seasoned lea…
Wells Fargo is a diversified U.S. bank operating consumer and commercial banking, corporate and investment banking, and wealth management, supported by a large deposit franchise, a $2.3 trillion asset base, nationwide advisory distribution, and increasingly relevant capital-markets capabilities. Business quality is high but not without legacy constraints: return on equity is 12.6%, gross margin i…
Accumulation Zones
| Metric |
MRK |
WFC |
| Zone Low |
$75.11 |
$77.53 |
| Zone High |
$85.12 |
$87.87 |
| In Buy Zone? |
No
|
Yes
|